立方制药(003020.SZ)发布前三季度业绩，归母净利润1.21亿元，同比增长1.65%

Core Viewpoint - The company reported a decline in revenue for the first three quarters of 2025, while net profit showed a slight increase, indicating mixed financial performance [1] Financial Performance - The company achieved operating revenue of 1.081 billion yuan for the first three quarters, representing a year-on-year decrease of 3.95% [1] - The net profit attributable to shareholders of the listed company was 121 million yuan, reflecting a year-on-year increase of 1.65% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 89.35 million yuan, which is a year-on-year decrease of 20.23% [1]